Standout Papers
Immediate Impact
2 from Science/Nature 78 hit
Citing Papers
Metabolic Dysfunction–Associated Steatotic Liver Disease
2025 Hit
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Hit
Works of Zeid Kayali being referenced
EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study
2021
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
2018 Hit
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Zeid Kayali | 1.0k | 760 | 303 | 281 | 198 | 33 | 1.5k | |
| Terese Haaland | 1.2k 1.2× | 623 0.8× | 436 1.4× | 367 1.3× | 299 1.5× | 17 | 1.7k | |
| Koji Yanase | 632 0.6× | 686 0.9× | 232 0.8× | 186 0.7× | 480 2.4× | 38 | 1.6k | |
| Takumi Igura | 1.0k 1.0× | 613 0.8× | 118 0.4× | 197 0.7× | 352 1.8× | 46 | 1.8k | |
| Rosa Lombardi | 1.1k 1.1× | 542 0.7× | 418 1.4× | 207 0.7× | 152 0.8× | 72 | 1.4k | |
| Gagan Sood | 1.1k 1.1× | 1.0k 1.3× | 262 0.9× | 739 2.6× | 127 0.6× | 35 | 1.8k | |
| Miwa Kawanaka | 1.4k 1.3× | 836 1.1× | 423 1.4× | 225 0.8× | 204 1.0× | 77 | 1.7k | |
| Monika Rau | 1.1k 1.1× | 386 0.5× | 357 1.2× | 221 0.8× | 546 2.8× | 44 | 1.7k | |
| Montserrat Elena | 597 0.6× | 523 0.7× | 129 0.4× | 521 1.9× | 277 1.4× | 28 | 1.6k | |
| Seigo Abiru | 959 0.9× | 861 1.1× | 82 0.3× | 170 0.6× | 248 1.3× | 52 | 1.5k | |
| Amer Khiyami | 949 0.9× | 401 0.5× | 699 2.3× | 468 1.7× | 121 0.6× | 41 | 1.6k |
All Works
Loading papers...